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In previous work from this laboratory, methionine containing peptides from the human 
urinary proteome were examined by mass spectrometry for the degree of methionine oxidation to 
the sulfoxide form. While this demonstrated that many of the methionines detected were capable 
of being oxidized, the question of whether these methionines are important in the structure 
and/or function of the parent proteins came about. In some proteins, methionine oxidation has 
been linked to conformational changes and alteration of function and thus can serve as a 
mechanism for reversible regulation of activity. It is hypothesized that methionines which might 
serve a regulatory purpose when cycled between the thioether and sulfoxide form will be 
conserved throughout many species. A list of species whose genomes have been sequenced was 
designed to span a wide distance across the phylogenetic tree, so that conservation of specific 
methionines could be analyzed. Some methionines that were susceptible to oxidation were found 
to be much more conserved than other methionines and also more conserved than their 
surrounding residues. It is hypothesized that upon further study, these methionines will prove to 
be more important to the structure and/or function of their respective proteins than the other 
methionines that were less conserved than their surroundings or those with a low overall 
conservation. Focusing future work to examine the impact upon protein structure and function of 
oxidation and reduction of this group of conserved methionines would seem more likely to be 
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Post-translational modifications of proteins serve a variety of purposes, but in many 
ways, an important underlying theme is that they affect the activity of proteins.  They, for 
example, may stabilize a protein, change it from one structure to another, reveal or conceal an 
active site, or alter a binding affinity. One of the various types of post-translational modifications 
which has received comparatively little attention is oxidation of methionine residues to the 
sulfoxide form.  
While other amino acids can be oxidized, cysteine and methionine are most susceptible.1 
The oxidation of methionine to methionine sulfoxide is particularly notable as a post-
translational modification as it is readily reversible, as reviewed briefly below. The utility of a 
reversible modification such as phosphorylation in regulation of protein activity is obvious from 
any introductory biochemistry course and, recently, it has been shown that the oxidation and 
reduction of methionine is important for the regulation of certain signaling proteins.2,3 
Interestingly, it has also been found that the oxidation of methionine often occurs simultaneously 
with other post-translational modifications. One study found that methionine residues that are 
more readily oxidized were located near amino acids that are readily phosphorylated.4 
While there is some evidence that methionine oxidation and reduction can serve a 
regulatory function, there are not a large number of examples.  In part this is likely because 
detection of the modification is much more difficult than determining if a protein is 
phosphorylated or cleaved.  There is no good spectroscopic signal, no charges are introduced or 
removed, and radioactive labeling is not practical.  The main way to determine if a specific 




the fact that the modification can occur fairly easily and a brief discussion of this process is in 
order. 
Reactive oxygen species (ROS), such as superoxide, singlet oxygen, ozone, peroxides, 
and hydroxyl and peroxyl radicals, are produced in cells as part of normal cellular functions, 
such as from NADPH oxidases.5-8 ROS can be introduced in the body through other means, such 
as smoking, as well. In the presence of reactive oxygen species, a 2-electron oxidation of 
methionine forms a double bond between the sulfur of a methionine residue and an oxygen atom 
from a ROS. Figure 1 shows the structures of both methionine and methionine sulfoxide.10 
Methionine sulfoxide (MetSO) exists in 2 epimers, an S configuration and an R configuration.1 
This oxidation changes the side chain of methionine from a smaller flexible hydrophobic chain to 
a larger, less flexible, hydrophilic chain.9 The sulfur of MetSO holds a partial positive charge and 
the oxygen carries a partial negative charge. These changes affect various protein-protein 
interactions and protein-substrate interactions.10 Even the reactivity of the side chain is altered as 
methionine can be alkylated while MetSO is resistant to alkylation.11  
 




Methionine sulfoxide reductase (MSR) returns methionine sulfoxide in peptides and 
proteins back to the thioether form of methionine. In order to reverse oxidation of both epimers 
of MetSO, two methionine sulfoxide reductases exist, MSRA and MSRB, each one specific for 
an epimer. MSRA reduces S-MetSO while MSRB reduces R-MetSO.12 Figure 2 shows the 
stereochemistry of each epimer of MetSO. MSRs contain cysteine residues in the active site that 
interact with the oxygen of MetSO in order to reduce it back to methionine. Figure 3 shows the 
mechanism of MSRA to reduce MetSO in bacteria, a similar mechanism to that of mammals.13  
The ability of methionine to undergo oxidation and reduction readily allows it to guard 
cells from oxidative damage.14,15 This is a general ability of any methionine that is accessible to 
ROS and to MSR and can be thought of as analogous to the role of the glutathione (GSH/GSSG) 
redox buffering system. Our interest here is not in this general capacity to react with and 
effectively neutralize ROS and protect the cell from damage, but rather in the possible effect of 
specific methionines to alter the function of the protein that they are a part of. The oxidation 
might be caused by a general increase in the concentration of oxidative species or it might be 








Figure 2. Formation of 2 epimers of methionine sulfoxide by ROS. The S configuration is 





Figure 3. Mechanism of reduction of methionine sulfoxide by MSRA in bacteria. The same 
mechanism is used in mammalian species to reduce methionine sulfoxide from dos Santos 
et. al.13 
 
One example of methionine oxidation as a role in cell signaling is the role it can play in 
oxidation-induced ion channels such as the thermosensitive transient receptor potential ion 
channels. This receptor has been studied in mice (though also present in humans) and was found 
to lose its oxidation-induced gating function almost completely when two specific methionine 
residues were substituted. This lost function is a necessary function for macrophages to perform 
phagocytic activity. Oxidation of these residues is critical for the ion channel to function.16  
 In calcium regulatory proteins such as calmodulin, the oxidation of methionine to 
methionine sulfoxide leads to a conformational change in the protein. This change prevents 
activity between proteins and their targets which then signals energy production to slow, leading 
to a slowed production of other reactive oxygen species.17,18 Another study performed in 




inactive. The presence of nitrogen reduces the MetSO back to methionine, activating NirA, a 
regulatory gene for nitrogen assimilation. It is believed that the reduction of MetSO to 
methionine exposes the activation domain of NirA due to a conformational change.19 
Methionine modification to methionine sulfoxide can also lead to the progression of 
various diseases. An example of this includes the decreased rate of the thrombomodulin-
thrombin complex to activate protein C, shifting hemostasis toward clot formation when the 
methionine at position 388 in thrombomodulin is oxidized to methionine sulfoxide.10 In contrast, 
the kinase CaMKII is activated by the oxidation of methionine residues M281 and M282 which 
causes association of the regulatory and catalytic domains and keeps CaMKII in the active state 
until oxidation is reversed by methionine sulfoxide reductase. When studied in mice, it was 
found that an increase in oxidation of CaMKII can lead to heart arrhythmias. When this same 
kinase is highly oxidized in lung tissues it can contribute to the development of asthma.20 In 
Apolipoprotein A-I, oxidation of Met148 prevents the activation of the enzyme lecithin-
cholesterol acyltransferase (LCAT) which is necessary for the conversion of cholesterol to 
cholesterol ester. This can lead to fatty plaque formation in arteries.20 Along with these 2 
examples, the same study also noted that oxidation of Met 388 in transmembrane protein TM, 
Met1606 in VWF (linked to von Willebrand disease), Met 46 and Met49 in actin, and Met78, 
Met367, and Met476 in fibrinogen have also been linked to the advancement of thrombosis and 
vascular disease.  
Methionine oxidation has also been linked to other diseases such as Parkinson’s Disease. 
Formation of MetSO in alpha-synuclein can lead to cytotoxicity connected to Parkinson’s 
Disease.21 In this case, there are 4 methionine residues that can be oxidized to MetSO. Oxidation 




was noted that the greater the number of oxidized methionine residues, the greater the inhibition 
of fibrillation in the non-oxidized protein.   
In Alzheimer’s disease, aggregation of amyloid beta proteins leads to cell death in 
neuronal cells. Studies have shown that methionine 35 in this protein can be readily oxidized to 
MetSO. One study found that this oxidation actually slowed the aggregation of the beta amyloid 
proteins which in turn slowed cell death. It was noted however that aggregation does still occur 
although at a slower rate therefore cell death still occurs.22 One study noted that the presence of 
MetSO in this protein may signal the activation of MSRA which could also help slow the rate of 
toxicity however, as age and oxidative stress increase, the activity of MSRA decreases.23 
Another study stated that it is possible this same methionine could donate just one electron and 
form a radical cation, which would be considered an irreversible oxidation of methionine. This 
oxidation could also lead to damage within the beta amyloid protein.24  
There are several clear examples of the use of methionine redox chemistry to regulate 
protein function.  But every solvent exposed methionine is susceptible to oxidation.25 How can 
we identify methionine residues that might be playing a regulatory role?  Previously, our 
laboratory conducted a proteomic study of human urine and identified some specific methionines 
that seem susceptible to oxidation. A general trend has been identified to show that an increase in 
the degree of conservation correlates to a higher role of importance that amino acids play in the 
structure or function of its protein.26-28 We hypothesize that methionines that are playing a redox 
regulatory role are more likely to be conserved than those that are not. By aligning human 
proteins with methionines with the sequences of homologous proteins from various species, one 
can determine the degree of conservation. It is expected that as distance across the phylogenetic 




for the structure or function of its protein, it is more likely to be conserved across a greater 
distance than a residue that is not as vital to the protein. A comparison of well conserved and less 
well conserved methionines is interesting.  
 Procedure 
In a previous study from this lab, human urine samples were collected from 40 
individuals. These samples were processed and analyzed using mass spectrometry which 
identified methionine containing peptides.29 An Excel sheet containing 308 methionine 
containing peptides, some of which contain more than one methionine, from 156 proteins was 
obtained from this previous study. The rate of oxidation of methionine to methionine sulfoxide in 
these peptides was calculated and included in this Excel sheet.  
 A conservation study was then performed on these proteins in order to identify which 
methionine residues were highly conserved and which residues were not conserved. To perform 
this study, the proteins identified from mass spectrometry were searched using the BLAST tool 
by inserting their protein accession number. The BLAST protocol was used to search for 
homologs of the identified proteins across a set list of 39 species, including humans. These 
species were selected to provide a broad range across the phylogenetic tree. The chosen species 
had also had their genomes sequenced, increasing the likelihood of finding homologs. This 
species list contains 23 mammals, 13 non-mammal chordates, and 3 non-chordates. The species 
list can be viewed in Table 1. A total of 26 proteins were not considered in the remainder of this 
study due to difficulties when using the BLAST search tool to find sequence homologs. Of these 
26 proteins identified using mass spectrometry, 11 resulted in only human sequences when 
searched using the BLAST tool, 2 consisted of a repeat sequence throughout making it unclear 




in a single peptide, which greatly complicated analysis. In addition, one detected peptide was 
matched to be a fragment of La-related protein 4. The accession code for this protein failed to 
run using the BLAST tool. A total of 9 proteins detected did not have calculated oxidation values 
and were therefore not used for this study on oxidation and conservation. The other 130 proteins 
were used in the remainder of this study.  
 
Table 1. Set species list used for setting BLAST parameters when search for protein 
sequences for a multiple sequence alignment. 
Species Common Name Taxonomic ID 
Mammals 
Homo sapiens Human 9606 
Gorilla gorilla Gorilla 9593 
Pongo abelii Sumatran orangutan 9601 
Otolemur garnettii Bushbaby 30611 
Mus musculus Mouse 10090 
Oryctolagus cuniculus European rabbit 9986 
Sus scrofa Wild boar 9823 
Bos primigenius taurus Cow 9913 





Table 1 (Cont.) 
Species Common Name Taxonomic ID 
Delphinapterus leucas Beluga whale 9749 
Neophocaena phocaenoides Finless porpoise 34892 
Felis catus Domestic cat 9685 
Canis lupus familiaris Domestic dog 9615 
Ailuropoda melanoleuca Giant panda 9646 
Odobenus rosmarus Walrus 9707 
Megaderma lyra Greater false vampire bat 9413 
Erinaceus europaeus Western European hedgehog 9365 
Elephas maximus Asian elephant 9783 
Trichechus manatus West Indian manatee 9778 
Ornithorhynchus anatinus Platypus 9258 
Phascolarctos cinereus Koala 38626 
Monodelphis domestica Gray short-tailed opossum 13616 
Sarcophilus harrisii Tasmanian devil 9305 
Non-mammal Chordates 




Table 1 (Cont.) 
Species Common Name Taxonomic ID 
Gallus gallus Chicken 9031 
Haliaeetus albicilla White-tailed eagle 8969 
Pogona vitticeps Central bearded dragon 103695 
Chelonia mydas Green sea turtle 8469 
Aliigator mississippiensis American alligator 8496 
Nanorana parkeri High Himalaya frog 125878 
Ambystoma mexicanum Axolotl 8296 
Gadus morhua Atlantic cod 8049 
Tetraodon nigroviridis Green spotted puffer 99883 
Oncorhynchus mykiss Rainbow trout 8022 
Petromyzon marinus Lamprey 7757 
Ciona savignyi Sea squirt 51511 
Non-chordates 
Saccoglossus kowalevskii Acorn worm 10224 
Acanthaster planci Crown of thorns starfish 133434 




The homolog searches were completed from January 2019 through September 2019 using 
the Basic Local Alignment Search Tool (BLAST) on the National Center for Biotechnology 
Information website.30 Due to the limitation of the number of species that can be specifically 
searched in one BLAST run, three links were created in order to obtain homolog sequences from 
all of the chosen species. All of the links opened the BLAST tool, each with the tax IDs of a 
portion of the species list from above uploaded into the search set parameters. The first link 
contained the species from Homo sapiens through Ornithorhynchus anatinus. The second link 
was set to search for Homo sapiens along with the species from Phascolarctos cinereus to 
Acanthaster planci. The third and final BLAST search was set to search for sequences belonging 
to Homo sapiens and Bacillus cereus. BLASTP was used to run a protein-protein BLAST search. 
The general parameter values were set as follows: max target sequences equal to 100, automatic 
parameter adjustments for short input sequences, expect threshold set to 10, word size set to 6, 
and max matches in a query range equal to 0. The scoring parameters were set as follows: matrix 
set to BLOSUM62, gap costs set to existence: 11 and extension: 1, and the compositional 
adjustments set to conditional compositional score matrix adjustment. Masking and filters were 
not selected.  
After using the BLAST search tool to find homologous proteins, sequence results were 
saved for the species from the list that had a matching protein sequence. All sequences were then 
saved into a Word document and aligned using the Clustal Omega online multiple sequence 
aligner (https://www.ebi.ac.uk/Tools/msa/clustalo/).31 Alignments were then saved in a Word 
document to be analyzed. Methionines in peptides that were detected by mass spectrometry were 
found in the human sequence within the alignment. Methionines conserved in homologous 




across all species. When counting conserved residues, the counts were taken for three groups: 
mammals, chordates (including mammals), and total conservation across the other 38 species. 
Humans were not included in these counts. Percent conservation was calculated for each of the 
three groups by dividing the number of conserved side chains at each position by the number of 
homologous proteins found. For example, if a protein BLAST search resulted in sequences for 
25 species, but only 15 of those sequences conserved the residue found in humans within those 
25, the percent conservation for the group of all species would be 15/25 or 60%. Conservation 
counts were also taken for three surrounding residues on each side of the methionine. The 
surrounding counts were averaged to give an average conservation count for the left (N-
terminus) and right (C-terminus) sides. These average counts were then divided by the total 
possible counts as before to give an average percent conservation for the N and C flanking 
sequences.  
In addition to calculating percent conservation in the above manner, ConSurf was used to 
find a conservation score for the methionines within the proteins. ConSurf is an online program 
that estimates conservation scores based on algorithms that take evolutionary models and 
phylogenetic distance into account. ConSurf also predicts whether a residue is more likely to be 
buried or exposed when calculating scores.26 ConSurf allows users to search for homologs and 
calculate conservation scores by either uploading a protein sequence or a PDB code. Both of 
these methods were used initially. When using ConSurf and uploading a PDB structure code for 
the protein, the sequence provided belonging to structure given with the uploaded PDB code did 
not identically match the sequence that was retrieved when running the BLAST search of the 
protein. In order to run the exact sequences downloaded from the BLAST search, the protein 




this, the parameters had to be set to select that a structure did not exist. While there are structures 
of many of the proteins detected in this study, we did not use these structures for ConSurf. 
However, ConSurf did match our uploaded sequence to known structures that were very similar 
in sequence to our proteins. The parameters in ConSurf were set to select up to 150 sequences 
that sampled a list of homologs that fell within a specified percent identity range. For this study, 
three ranges of percent identity were created to allow for a sequence search that spanned more 
broadly across the phylogenetic tree. These ranges were: 35% minimal to 95% maximum (the 
default setting which most often gave results that were 80% or greater identity match and thus 
relatively close in the phylogenetic tree), 40% to 65%, and 10% to 35%. By using these 3 ranges, 
results were obtained not only from various classes of animals but also from some plants and 
fungi. 
Results and Discussion 
After all the proteins from which one or more methionine containing peptides detected in 
a proteomic study of human urinary proteins were aligned and conservation of the methionine 
and surrounding residues was calculated, a PIVOT table was created with the data. The 
percentage of methionine conservation among the 39 species is plotted in Figure 4 against the 
percent oxidation found in the proteomics data for that methionine. Note that some or even all of 
the oxidation might have occurred during processing of the samples and it is equally possible 
that a methionine might have been detected for unknown reasons in only the oxidized or reduced 
forms.  In other words, the percentage of oxidation we observed is only a crude indicator that 
such an oxidation event is possible and by no means definitive evidence that it occurs under 
physiological conditions. However, this is the only broadly sampled data we are aware indicating 




percentage of oxidation was found in this work. As expected, even poorly conserved methionines 
are susceptible to oxidation and some highly conserved methionines showed only a slight 
propensity to found in the oxidized state.   
Again, reasoning that the methionines that are most likely to have possible redox 
regulatory role are those that can be oxidized readily and those that are well conserved, we 
somewhat arbitrarily selected for more detailed investigation of proteins with one or more 
methionines with 80% or greater conservation as well as 50% or greater oxidation, falling in the 
upper right of Figure 4. A list of these methionine containing peptides and their corresponding 
proteins can be found in Table 2. A second group of peptides containing methionines with a low 
methionine oxidation percentage and high percentage of methionine conservation was also 
selected to compare to the high conservation, high oxidation proteins. The range for this list of 
methionines was greater than 80% conservation but less than 50% oxidation (lower right of 
Figure 4) and can be viewed in Table 3.  
A plot was also created to determine which proteins on average fell into these same two 
groups as described above. Figure 5 was created by averaging the percentage of oxidation and 
percentage of conservation of all methionines within a protein. Each data point represents a 
different protein. Those proteins that had an average of 80% or greater conservation and an 
average of 50% or greater oxidation, which fall in the upper right of Figure 5, are listed in Table 
4. The proteins that had an average of 80% or greater conservation and an average of less than 
50% oxidation, which fall in the lower left of Figure 5, are listed in Table 5. The proteins in both 









Figure 5. Scatter plot of average % oxidation vs. average % conservation of methionine 










Table 2. Methionines of interest selected with greater than 80% conservation and greater than 50% oxidation. 
Protein 
Accession 





P02533 Keratin, type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 272 100 100 
P08779 Keratin, type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4 274 100 100 
P0C0L4 Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=2 1128 100 100 
P13645 Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 306 100 100 
P13647 Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 457 100 70.07 
P15311 Ezrin OS=Homo sapiens GN=EZR PE=1 SV=4 200 100 100 
P35527 Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 326 100 100 
P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 305 100 73.07 
P68032 Actin, alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 229 96.9697 100 
P98164 Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens 
GN=LRP2 PE=1 SV=3 
1905 96.77419 85.41 
P13797 Plastin-3 OS=Homo sapiens GN=PLS3 PE=1 SV=4 169 96.66667 100 
Q9NZH0 G-protein coupled receptor family C group 5 member B OS=Homo sapiens 
GN=GPRC5B PE=2 SV=2 
381 96.66667 59.2 
P54802 Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 
SV=2 
238 96.55172 66.39 
P06753 Tropomyosin alpha-3 chain OS=Homo sapiens GN=TPM3 PE=1 SV=2 11 96.42857 100 
Q02413 Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2 208 96.42857 100 
O43707 Alpha-actinin-4 OS=Homo sapiens GN=ACTN4 PE=1 SV=2 679 96.2963 100 
P29508 Serpin B3 OS=Homo sapiens GN=SERPINB3 PE=1 SV=2 40 96.2963 100 
Q96P63 Serpin B12 OS=Homo sapiens GN=SERPINB12 PE=1 SV=1 41 96.15385 58.98 
P04745 Alpha-amylase 1 OS=Homo sapiens GN=AMY1A PE=1 SV=2 338 93.75 82.43 
Q562Z4 Actin-like protein (Fragment) OS=Homo sapiens GN=ACT PE=3 SV=1 70 93.54839 53.82 
O00560 Syntenin-1 OS=Homo sapiens GN=SDCBP PE=1 SV=1 57 93.33333 63.43 
P07339 Cathepsin D OS=Homo sapiens GN=CTSD PE=1 SV=1 201 93.33333 66.68 
P07384 Calpain-1 catalytic subunit OS=Homo sapiens GN=CAPN1 PE=1 SV=1 438 93.10345 51.1 







Table 2. (Cont.) 
Protein 
Accession 





P51654 Glypican-3 OS=Homo sapiens GN=GPC3 PE=1 SV=1 316 93.10345 50.56 
P02787 Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 483 92.59259 60.68 
P13646 Keratin, type I cytoskeletal 13 OS=Homo sapiens GN=KRT13 PE=1 SV=4 340 92.30769 100 
P02751 Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 1548 91.66667 100 
P35908 Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 
SV=2 
467 91.30435 50.93 
P11142 Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 
SV=1 
61 90.90909 100 
P05155 Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 
SV=2 
324 90 88.91 
P68431 Histone H3.1 OS=Homo sapiens GN=HIST1H3A PE=1 SV=2 94 90 59.26 
Q8N4F0 BPI fold-containing family B member 2 OS=Homo sapiens GN=BPIFB2 
PE=1 SV=2 
254 90 55.76 
P02538 Keratin, type II cytoskeletal 6A OS=Homo sapiens GN=KRT6A PE=1 SV=3 242 88.46154 100 
P04264 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 296 88.46154 50.35 
Q8WZ42 Titin OS=Homo sapiens GN=TTN PE=1 SV=4 16670 88 100 
P01011 Alpha-1-antichymotrypsin OS=Homo sapiens GN=SERPINA3 PE=1 SV=2 284 87.5 51.42 
P10253 Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 671 87.09677 59.31 
P15144 Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 212 87.09677 77.03 
P07602 Prosaposin OS=Homo sapiens GN=PSAP PE=1 SV=2 255 86.66667 75.62 
P07737 Profilin-1 OS=Homo sapiens GN=PFN1 PE=1 SV=2 86 86.66667 100 
P05067 Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 303 85.71429 100 
Q92616 eIF-2-alpha kinase activator GCN1 OS=Homo sapiens GN=GCN1 PE=1 
SV=6 
1377 84.84848 100 
P13647 Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 247 84.61538 100 
P04745 Alpha-amylase 1 OS=Homo sapiens GN=AMY1A PE=1 SV=2 302 84.375 59.19 
Q2M2H8 Probable maltase-glucoamylase 2 OS=Homo sapiens GN=MGAM2 PE=2 
SV=3 







Table 2. (Cont.) 
Protein 
Accession 





A8K2U0 Alpha-2-macroglobulin-like protein 1 OS=Homo sapiens GN=A2ML1 PE=1 
SV=3 
1371 84 50.59 
P10253 Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 427 83.87097 64.54 
P15144 Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 249 83.87097 100 
P08185 Corticosteroid-binding globulin OS=Homo sapiens GN=SERPINA6 PE=1 
SV=1 
76 80.76923 100 
Q99456 Keratin, type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 251 80.76923 59.66 
P98164 Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens 
GN=LRP2 PE=1 SV=3 
2629 80.64516 100 



















Table 3. Methionines of interest selected with greater than 80% conservation and less than 50% oxidation. 
Protein 
Accession 





P06870 Kallikrein-1 OS=Homo sapiens GN=KLK1 PE=1 SV=2 122 100 30.24 
P06870 Kallikrein-1 OS=Homo sapiens GN=KLK1 PE=1 SV=2 197 100 36.17 
P15144 Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 486 100 37.44 
P35527 Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 157 100 21.9 
P35908 Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 
SV=2 
337 100 16.44 
P61626 Lysozyme C OS=Homo sapiens GN=LYZ PE=1 SV=1 35 100 32.87 
P68032 Actin, alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 192 100 41.33 
P00450 Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 259 96.77419 44.08 
P07339 Cathepsin D OS=Homo sapiens GN=CTSD PE=1 SV=1 219 96.66667 45.11 
O43707 Alpha-actinin-4 OS=Homo sapiens GN=ACTN4 PE=1 SV=2 328 96.2963 37.5 
O43707 Alpha-actinin-4 OS=Homo sapiens GN=ACTN4 PE=1 SV=2 883 96.2963 48.02 
P13647 Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 284 96.15385 43.95 
P02751 Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 1283 95.83333 30.51 
P02751 Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 1783 95.83333 12.62 
Q7Z3Y9 Keratin, type I cytoskeletal 26 OS=Homo sapiens GN=KRT26 PE=1 SV=2 87 95.83333 37.04 
Q16769 Glutaminyl-peptide cyclotransferase OS=Homo sapiens GN=QPCT PE=1 
SV=1 
223 93.75 24.4 
P98164 Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens 
GN=LRP2 PE=1 SV=3 
1004 93.54839 39.97 
P30740 Leukocyte elastase inhibitor OS=Homo sapiens GN=SERPINB1 PE=1 SV=1 228 93.10345 4.08 
P30740 Leukocyte elastase inhibitor OS=Homo sapiens GN=SERPINB1 PE=1 SV=1 307 93.10345 39.37 
P54107 Cysteine-rich secretory protein 1 OS=Homo sapiens GN=CRISP1 PE=1 SV=1 65 93.10345 33.25 
P29508 Serpin B3 OS=Homo sapiens GN=SERPINB3 PE=1 SV=2 243 92.59259 27.83 
P41222 Prostaglandin-H2 D-isomerase OS=Homo sapiens GN=PTGDS PE=1 SV=1 145 92.30769 26.49 








Table 3. (Cont.) 
Protein 
Accession 





Q8WUM4 Programmed cell death 6-interacting protein OS=Homo sapiens 
GN=PDCD6IP PE=1 SV=1 
358 90.90909 34.05 
P04745 Alpha-amylase 1 OS=Homo sapiens GN=AMY1A PE=1 SV=2 117 90.625 33.54 
Q12907 Vesicular integral-membrane protein VIP36 OS=Homo sapiens GN=LMAN2 
PE=1 SV=1 
277 90.32258 43.58 
P15309 Prostatic acid phosphatase OS=Homo sapiens GN=ACPP PE=1 SV=3 75 90 39.04 
P15309 Prostatic acid phosphatase OS=Homo sapiens GN=ACPP PE=1 SV=3 75 90 39.75 
P55290 Cadherin-13 OS=Homo sapiens GN=CDH13 PE=1 SV=1 267 89.65517 33.29 
O43707 Alpha-actinin-4 OS=Homo sapiens GN=ACTN4 PE=1 SV=2 767 88.88889 22.58 
P29508 Serpin B3 OS=Homo sapiens GN=SERPINB3 PE=1 SV=2 275 88.88889 29.19 
P29508 Serpin B3 OS=Homo sapiens GN=SERPINB3 PE=1 SV=2 317 88.88889 47.57 
P04264 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 296 88.46154 36.66 
P04264 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 469 88.46154 25.73 
P41222 Prostaglandin-H2 D-isomerase OS=Homo sapiens GN=PTGDS PE=1 SV=1 64 88.46154 14.58 
P41222 Prostaglandin-H2 D-isomerase OS=Homo sapiens GN=PTGDS PE=1 SV=1 64 88.46154 27 
P02751 Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 926 87.5 38.75 
Q16769 Glutaminyl-peptide cyclotransferase OS=Homo sapiens GN=QPCT PE=1 
SV=1 
65 87.5 43.96 
P10253 Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 695 87.09677 43.73 
P09668 Pro-cathepsin H OS=Homo sapiens GN=CTSH PE=1 SV=4 200 84.84848 29.13 
P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 153 84.84848 9 
P05154 Plasma serine protease inhibitor OS=Homo sapiens GN=SERPINA5 PE=1 
SV=3 
275 84.61538 12.89 
Q12907 Vesicular integral-membrane protein VIP36 OS=Homo sapiens GN=LMAN2 
PE=1 SV=1 
271 83.87097 41.22 
O60494 Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 2069 83.33333 46.15 
P05090 Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 177 83.33333 26.45 







Table 3. (Cont.) 
Protein 
Accession 





P98164 Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens 
GN=LRP2 PE=1 SV=3 
1299 80.64516 9.06 
P98164 Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens 
GN=LRP2 PE=1 SV=3 























Table 4. Proteins of interest selected with greater than 80% conservation and greater than 50% oxidation. 
Protein Accession Number Protein Average % Conservation Average % Oxidation 
P15311 Ezrin 100.0 100.0 
P0C0L4 Complement C4-A 100.0 100.0 
P08779 Keratin, type I cytoskeletal 16 100.0 100.0 
P02533 Keratin, type I cytoskeletal 14 100.0 100.0 
P68032 Actin, alpha cardiac muscle 1 98.5 70.7 
Q9NZH0 G-protein coupled receptor family C 
group 5 member B 
96.7 59.2 
P13797 Plastin-3 96.7 100.0 
P54802 Alpha-N-acetylglucosaminidase 96.6 66.4 
P06753 Tropomyosin alpha-3 chain 96.4 100.0 
Q96P63 Serpin B12 96.2 59.0 







Table 4. (Cont.) 
Protein Accession Number Protein Average % Conservation Average % Oxidation 
Q562Z4 Actin-like protein (Fragment) 93.5 53.8 
O00560 Syntenin-1 93.3 63.4 
P51654 Glypican-3 93.1 50.6 
P07384 Calpain-1 catalytic subunit 93.1 51.1 
P13646 Keratin, type I cytoskeletal 13 92.3 100.0 
P11142 Heat shock cognate 71 kDa protein 90.9 100.0 
Q8N4F0 BPI fold-containing family B member 
2 
90.0 55.8 
P68431 Histone H3.1 90.0 59.3 
P13645 Keratin, type I cytoskeletal 10 89.1 66.4 
P02538 Keratin, type II cytoskeletal 6A 88.5 100.0 







Table 4. (Cont.) 
Protein Accession Number Protein Average % Conservation Average % Oxidation 
P07737 Profilin-1 86.7 100.0 
P05067 Amyloid beta A4 protein 85.7 100.0 
Q92616 eIF-2-alpha kinase activator GCN1 84.8 100.0 
Q2M2H8 Probable maltase-glucoamylase 2 84.4 96.8 
P04745 Alpha-amylase 1 82.0 55.1 
Q99456 Keratin, type I cytoskeletal 12 80.8 59.7 














Table 5. Proteins of interest selected with greater than 80% conservation and less than 50% oxidation. 
Protein Accession Number Protein Average % Conservation Average % Oxidation 
P06870 Kallikrein-1 100.0 33.2 
P61626 Lysozyme C 100.0 32.9 
Q7Z3Y9 Keratin, type I cytoskeletal 26 95.8 37.0 
P02751 Fibronectin 92.7 45.5 
P60709 Actin, cytoplasmic 1 92.4 41.0 
Q9UNN8 Endothelial protein C receptor 91.7 0.0 
Q8WUM4 Programmed cell death 6-interacting 
protein 
90.9 34.1 
P55290 Cadherin-13 89.7 33.3 
Q12907 Vesicular integral-membrane protein 
VIP36 
87.1 42.4 
P35908 Keratin, type II cytoskeletal 2 
epidermal 
 87.0 30.6 







Table 5 (Cont.) 
Protein Accession Number Protein Average % Conservation Average % Oxidation 
P09668 Pro-cathepsin H 84.8 29.1 
P30740 Leukocyte elastase inhibitor 83.6 36.3 





    
 
Scatter plots were also created for the proteins to examine how the percent conservation 
of methionine compared to the percent conservation of the surrounding residues. The first scatter 
plot, Figure 6, shows the average percent conservation of the three residues to the left, or on the 
N-terminus side, of the detected methionine compared to the percent conservation of the 
methionine residues within a protein. Figure 7 shows the average percent conservation of the 
three residues to the right, or on the C-terminus side, of the detected methionine compared to the 
percent conservation of the methionine residues detected within a protein. The overall average 
percent conservation of the surroundings was calculated by averaging the C-terminus and N-
terminus percent conservations together. This average was plotted with the percent conservation 
of the methionine in Figure 8. One protein, Cystatin-A, was not included in these graphs because 
the detected methionine was at position 1, therefore conservation of surroundings could only be 
counted for the C-terminus side of the methionine.  
Using Figures 6, 7, and 8 it was determined that in general, the degree of methionine 
conservation correlated with the degree of conservation of the surrounding residues. However, 
methionine is generally less conserved than the surrounding residues. Because there is only one 
codon that corresponds to methionine, it is expected that methionine would be less conserved 
than any other amino acid except for tryptophan, also with only a single codon. A change in any 
of the three positions in the codon would result in a mutation from methionine.  In Figures 6, 7, 
and 8, a line runs through the plot. Any points below this line represent detected methionines that 
are more conserved than the average of its surroundings. This greater than expected conservation 
may indicate a greater degree of selective pressure on these residues, preserving them as 
methionines.Therefore, the methionine residues that fell below the line and were above 70% 
conserved were selected as residues of interest. These residues should be examined further for 
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the impact of oxidation and reduction on the protein. These selected methionines are represented 
in Tables 6-10. 
Figure 6. Average percentage of conservation of residues on the N-terminus of the detected 
methionine and percentage of conservation of the detected methionine residues. 
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 Figure 7. Average percentage of conservation of residues on the C-terminus of the detected 




    
 
      
Figure 8. Average percentage of conservation of residues on the N and C-terminus of the 








    
 
For the proteins with conserved methionines with high or low oxidation levels, ConSurf 
was also used in order to calculate conservation.26 Using ConSurf, conservation scores were 
generated over the three identity ranges described in methods (the default 35-95% conservation 
which typically resulted in alignment of only proteins with overall high levels of overall 
conservation close to humans in the phylogenetic tree, a mid-range of overall conservation of 40-
65% and the most divergent range 10-35% range of overall conservation, aligning species far 
from humans on the phylogenetic tree). In addition to the conservation data for these three 
ranges, the multiple sequence alignments between the set list of species determined as described 
earlier generated by Clustal Omega for the proteins of interest were uploaded into ConSurf in 
order to compare the ConSurf conservation scores for these alignments with the scores calculated 
using the sequences matched within the three percent identity ranges set in ConSurf. The % total 
conservation scores calculated previously were also compared. These results are summarized in 
Table 11, which compares the conservation scores for those proteins determined to have an 
average methionine conservation greater than 80% and an average methionine oxidation of 
greater than 50% and Table 12, which compares the conservation scores for those proteins 
determined to have an average methionine conservation greater than 80% but an average 
methionine oxidation of less than 50%.   
In Tables 11 and 12, the “score (normalized)” row is the normalized conservation score 
produced by ConSurf. The more negative scores represent residues that are more highly 
conserved while the more positive scores represent the residues that are less conserved 
throughout various homologues. The “color” value is assigned by ConSurf as a number 1-9 
matched to the conservation scores, where 9 is the most highly conserved and 1 is the least 
conserved. If a known structure of the protein exists, this color identification matches each 
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number to a specific color in order to color code residues based on their conservation scores. The 
“confidence interval” row is representative of the conservation interval determined by ConSurf 
for the normalized score. The “confidence interval color” row is the confidence interval for the 
color number assigned to the residue. The “percent” column represents the conservation 
percentages calculated with all possible sequences for the set species list described in Table 1 
obtained before using ConSurf. Tables 13 and 14 summarize these findings by only focusing on 
the color value assigned and the percentage of conservation calculated. In some cases, the 
ConSurf program failed to run the sequence given. In most of these instances, there were not 
enough homologues matched to properly align the sequences and calculate a conservation score. 
Titin failed to run in ConSurf because the sequences uploaded were too large for the program. 
Lysozyme C failed to run using the Clustal upload because less than 5 of the species from the 
created list had sequence results from using the BLAST search tool. ConSurf requires a 
minimum of 5 matches in order to calculate a conservation score. Reproducibility of ConSurf 
was verified by rerunning several proteins at each of the specified percent identity ranges 7-10 
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Table 13. Summary of ConSurf results for proteins with an average percentage of conservation greater than 80% and an 
average percentage of oxidation greater than 50%. “Close” represents the ConSurf search with up to a 95% identity. “Mid” 
represents the ConSurf search with a 40-65% identity match. “Far” represents the ConSurf search using 10-35% identity match. 
“Clustal” represents the ConSurf search using the multiple sequence alignment downloaded from Clustal using the set species list. 
Each number in the “Close”, “Mid”, “Far”, and “Clustal” column represents a number, 1-9, assigned by ConSurf where 1 is the least 
conserved and 9 is the most conserved.  
Protein Methionine Position Close Mid Far Clustal % Conservation 
Actin, alpha cardiac muscle 1 192 4 2 4 8 100.0% 
229 3 2 3 5 97.0% 
eIF-2-alpha kinase activator GCN1 1377 6 5 8 4 84.9% 
Keratin, type I cytoskeletal 14 272 8 8 6 9 100.0% 
Syntenin-1 57 9 9 5 9 93.3% 
Alpha-actinin-4 328 4 3 7 8 96.3% 
679 1 1 2 8 96.3% 
767 5 4 5 1 88.9% 
883 9 9 8 8 96.3% 
Ezrin 200 9 9 8 9 100.0% 
Complement C4-A 1128 9 9 8 9 100.0% 
Keratin, type I cytoskeletal 16 274 8 8 5 9 100.0% 
G-protein coupled receptor family C 
group 5 member B 
381 8 8 6 9 96.7% 
Plastin-3 169 7 7 6 7 97.0% 
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Table 13(Cont.) 
Protein Methionine Position Close Mid Far Clustal % Conservation 
Alpha-N-acetylglucosaminidase 238 9 9 8 9 96.6% 
Tropomyosin alpha-3 chain 11 8 4 4 9 96.4% 
Serpin B12 41 8 9 8 9 96.15% 
Actin-like protein (fragment) 70 5 7 6 1 93.6% 
Glypican-3 316 3 2 6 8 93.1% 
Calpain-1 catalytic subunit 438 4 3 1 9 93.1% 
Keratin, type I cytoskeletal 13 341 6 6 7 7 92.3% 
Heat shock cognate 71 kDa protein 61 6 1 6 4 90.9% 
BPI fold-containing family B member 2 254 9 Error 9 8 90.0% 
Histone H3.1 94 1 1 4 1 90.0% 
Keratin, type I cytoskeletal 10 291 7 6 6 8 78.3% 
306 8 8 9 9 100.0% 
Keratin, type II cytoskeletal 6A 242 6 6 6 7 88.5% 
Titin 16670 Error Error Error Error 88.0% 
Profilin-1 86 8 7 7 7 86.7% 
Amyloid beta A4 protein 303 6 1 Error 2 85.7% 
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Table 13(Cont.) 
Protein Methionine Position Close Mid Far Clustal % Conservation 
Alpha-amylase 1 117 9 9 8 9 90.6% 
198 6 5 8 3 59.4% 
302 4 4 4 6 84.4% 
338 8 7 6 8 93.75 
Keratin, type I cytoskeletal 12 251 5 5 5 5 80.8% 
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Table 14. Summary of ConSurf results for proteins with an average percentage of conservation greater than 80% and an 
average percentage of oxidation less than 50%. “Close” represents the ConSurf search with up to a 95% identity. “Mid” represents 
the ConSurf search with a 40-65% identity match. “Far” represents the ConSurf search using 10-35% identity match. “Clustal” 
represents the ConSurf search using the multiple sequence alignment downloaded from Clustal using the set species list. Each number 
in the “Close”, “Mid”, “Far”, and “Clustal” column represents a number, 1-9, assigned by ConSurf where 1 is the least conserved and 
9 is the most conserved.  
Protein Methionine Position Close Mid Far Clustal % Conservation 
Kallikrein-1 122 Error 9 8 9 100.0% 
197 Error 9 7 9 100.0% 
Lysozyme C 35 6 6 6 Error 100.0% 
Keratin, type I cytoskeletal 26 87 9 9 8 8 95.9% 
Fibronectin 926 6 7 Error 3 87.5% 
1283 3 6 Error 9 95.8% 
1548 7 7 Error 5 91.7% 
1783 9 9 Error 9 95.8% 
Actin, cytoplasmic 1  153 4 5 7 1 84.8% 
305 8 7 7 9 100.0% 
Endothelial protein C receptor  30 8 8 4 8 91.7% 
Programmed cell death 6-interacting 
protein 
358 9 9 8 7 90.9% 
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Table 14 (Cont.) 
Keratin, type II cytoskeletal 2 
epidermal 
294 6 Error 5 4 69.6% 
337 9 Error 7 9 100.0% 
467 8 Error 9 8 91.3% 
Glutaminyl-peptide cyclotransferase 65 6 4 1 7 87.5% 
223 7 7 4 8 93.8% 
332 2 1 2 5 75.0% 
Pro-cathepsin H 200 5 5 5 8 84.8% 
Leukocyte elastase inhibitor 156 1 1 3 1 55.2% 
228 9 9 9 8 93.1% 
307 7 8 7 8 93.1% 
Apolipoprotein D 177 8 7 7 7 83.3% 
Vesicular integral-membrane protein 
VIP36 
271 5 5 7 4 83.9% 








When using ConSurf, as expected, conservation scores generally decreased as 
phylogenetic distance increased although there were some residues within the tested proteins that 
had higher conservation scores in the low % match category than in the high % match category.  
It was determined that when uploading alignments generated by Clustal using the set species list 
as described in Table 1, the conservation scores tended to be higher and of more significance 
than the conservation scores obtained when ConSurf chose which homologs to align. This 
indicates that while some residues may not seem too highly conserved or of a large importance 
when only using ConSurf, those same residues can be of significance in ConSurf when the 
species list is restricted to those in Table 1.  
In addition to running the protein sequences through ConSurf in order to verify the 
conservation numbers calculated in this study, individual research was done to see if any of the 
proteins of interest had already been studied for the effect of oxidation of methionine residues on 
the protein’s structure and function. Several of the proteins of interest had been previously 
studied for the effect of the formation of MetSO on the protein. Below are summaries of the 
findings of some of the proteins of interest.  
Profilin-1 was found to be a protein of interest with 100% oxidation and over 85% 
conservation in all 3 groups of species. In this study it was found that the methionine at position 
86 was oxidized. Profilin-1 is an isoform of profilin which is a protein that binds to actin for 
structural support of the cytoskeleton. It was found that profilin binds to actin at residues 128-
134 of profilin.32 It was also discovered that when profilin is present at high concentrations, actin 
will not polymerize. When profilin is present at low concentrations, actin polymerization 
increases.33 Profilin has also been found to bind to phosphatidylinositol-4,5-bisphosphate.32 The 




ALS (amyotrophic lateral sclerosis). When a mutation occurs at this position, changing 
methionine to threonine, the structure of profilin-1 becomes destabilized due to the creation of a 
cleft in the protein.34 Possible treatment options for ALS were studied by targeting this cleft. 
Although this specific methionine residue was not detected in the current study, it is interesting 
to note that the normalized conservation score for this residue was highly conserved with a value 
of -0.724 and a confidence interval ranging from -0.969 to -0.602 when the percent identity 
range was set from 35% to 95% identity.  
As mentioned in the introduction, beta amyloid proteins are of interest in the study of 
Alzheimer’s Disease (AD). It has been found that amyloid beta aggregates in the cells of 
Alzheimer’s patients leading to cell death. In previous studies, it was found that methionine 35 of 
beta amyloid readily oxidizes to methionine sulfoxide and this formation of MetSO slows the 
aggregation of the proteins.22,35 One study in particular noted that this oxidation leads to a 
conformational change by unwinding the helix of bound proteins at the C-terminus. Following 
this unwinding, it was noted that interactions become unstable and the C-terminus of this protein 
begins to interact more strongly with lipids of the cell bilayer. This interaction prevents the rest 
of the protein from binding with the bilayer, reducing the overall affinity that amyloid beta has 
for the bilayer.22 This previous study was performed on peptides made of up to 40 residues that 
are cleaved from a precursor protein such as the beta amyloid A4 protein studied here. In this 
current study, a small peptide was detected with an oxidized methionine. The peptide identified 
was matched to have originated from the amyloid beta A4 protein. When this protein was 
sequenced, the identified methionine was from position 303 of the amyloid beta A4 precursor. 
When the beta amyloid peptide studied in AD was aligned with the amyloid beta A4 from this 




methionine residue was not detected, it is clear that methionine oxidation plays a major role in 
the progression of AD.  
Actin has 6 different isoforms. These isoforms are very similar, only differing by a few 
residues primarily at the N terminus.36 In this study, peptides from actin, cytoplasmic 1 and actin, 
alpha cardiac muscle 1 were detected. In actin, cytoplasmic 1, methionine oxidation to MetSO 
has been noted at residues 44 and 47. It was found that the formation of MetSO at positions 44 
and 47 promotes actin disassembly while the reduction of MetSO back to methionine promotes 
actin assembly. In the original study on these two residues, they were identified as residues 46 
and 49. In the PDB, these residues were matched to residues 44 and 47 of human actin, 
cytoplasmic 1.37 In this current study, MetSO formation was found at residues 153 and 305 of 
actin, cytoplasmic 1. Residues of actin, cytoplasmic 1 were not detected at positions 44 or 47. 
Another study found that many methionine residues can be oxidized. These residues were found 
to be located at positions 44, 47, 176, 190, 227, 269, and 355 in actin. It was also noted that 
Met82 can form a sulfone.38 In the current study methionine residues at positions 192 and 229 
were detected in the sulfoxide form in actin, alpha cardiac muscle 1. These residues when 
aligned with actin, cytoplasmic 1 align at positions 190 and 227, two of the residues previously 
identified as sites of methionine sulfoxide formation. Met190 was found to be one of two 
methionine residues that when oxidized completely prevents polymerization. It was noted that in 
F-actin, Met227 is less accessible than in G-actin.38  
Alpha-1-antitrypsin has also previously been studied for the effect of methionine 
oxidation on protein structure. In our study, methionines at positions 250, 375, and 382 were 
detected however none of these methionines were determined to be of high interest because of 




M375 was found to be only 12% conserved and 36.5% oxidized. M382 was also determined to 
be 64% conserved and 38.8% oxidized. Interestingly, these same methionines when studied 
previously, although not chosen as targets of interest here, were found to have a significant effect 
on the structure of alpha-1-antitrypsin39. M250, M375, and M382 align to positions 226, 351, 
and 358 of the previous study. In that particular study, it was determined that oxidation of M351 
or M358, both of which lie in the reactive center loop of alpha-1-antitrypsin, leads to a loss of 
inhibitory activity against neutrophil elastase. It was also discovered that oxidation of M358 can 
lead to a loss of inhibitory activity against pancreatic elastase. M226, which lies near and is 
hydrogen bonded to the reactive center loop, was also oxidized and it was noted that this 
oxidation could occur due to a conformational change induced by oxidation of M351 and M358, 
making M226 more solvent exposed. Similar to alpha-1-antitrypsin, we detected methionines of 
interest in alpha-1-antichymotrypsin. Of the four detected methionines, two were considered to 
be potentially interesting due to their higher percentage of conservation. M205 of alpha-1-
antichymotrypsin was 75% conserved and 89.4% oxidized. M284 was determined to be 87.5% 
conserved and 51.4% oxidized. The sequence of alpha-1-antichymotrypsin was aligned with that 
of alpha-1-antitrypsin. It was determined that these methionines were not conserved in alpha-1-
antitrypsin. The other two detected methionines, M204 and M219, were also not conserved 
between alpha-1-antichymotrypsin and alpha-1-antitrypsin. These two methionines were 
determined to have conservation percentages of 12.5% and 16.7%, respectively. Previous studies 
on these methionines or other methionines of alpha-1-antichymotrypsin have not yet been found.  
While not regulatory, oxidation of methionines in apolipoprotein D was found to be 
involved in reduction of hydroperoxyeicosatetraenoic acid (HpETE) to hydroxyeicosatetraenoic 




previous study, M93 was found to be the primary methionine involved in this reduction, but 
M157 was also determined to be involved in this reduction of HpETE to HETE.40 These 
methionines align to positions 113 and 177, respectively, in our study. While M113 was not 
detected, M177 was detected and determined to be of potential interest because it was found to 
have a conservation percentage of 83.3%.  
A previous study on complement C4 found that 52.6% of methionine residues were 
oxidized.41 It was suggested that because complement C4 belongs to the alpha-2-macroglobulin 
family, this oxidation of methionine residues could lead to activation of the protein. In our study 
of complement C4-A, one methionine residue was detected at position 1128 and was determined 
to be potentially interesting due to a conservation percentage of 100%. Our study also detected 
several methionines in alpha-2-macroglobulin-like protein 1. Of seven detected methionines, 
only one was determined to be of interest. M1116 had a conservation percentage of 72%. While 
it is not clear whether this particular methionine may play an important role in alpha-2-
macroglobulin, oxidation of four other residues has been shown to suppress the function of the 
protein. One residue in particular, M358 (not detected in our study), can lead to a complete loss 
in protein function when oxidized.42  
A final example is that of fibronectin. A previous study on fibronectin found that of the 
14 methionines that they detected, only 3 were determined to be targets of oxidation.43 Those 
methionines were at positions 926, 1783, ad 2050. Of those 3 methionines, 2 were detected in 
our study. M926 and M1783, along with M1283 and M1548, were detected in our study. Of 
those, all except for M1548 were determined to be of interest. M1548 should not be ignored 
however. The percentage of conservation for M1548 was high at 91.7% and was found to be 




residues were more highly conserved than the methionine itself. M926, M1283, and M1783 had 
conservation percentages of 87.5%, 95.8%, and 95.8% while their surrounding residues were all 
less conserved than the methionine. It is not yet understood what role these particular 
methionines carry out in the function of fibronectin.  
Conclusions 
 This study identified a list of potentially important methionine residues within proteins 
that may serve a critical role in determining a protein’s structure or carrying out its function. 
Within this study it is clear that some methionine residues are much more conserved than others 
indicating that they may be of greater importance. Some of the identified residues of importance 
within the selected proteins of interest have already been identified as being highly involved in 
structural or functional roles. While several of the identified proteins of interest have already 
been studied for the effect of MetSO formation, this list could potentially provide target proteins 
to be further studied to determine the effect of MetSO formation. Those methionines that were 
not chosen as methionines of interest should not be ignored however. As revealed in the 
examination of alpha-1-antitrypsin, residues not considered to be of high interest here could still 
be vital for a protein’s function. This list of residues and proteins of interest, while they should 
not be considered as the only residues of interest, could serve as a “map” of where to focus 
future studies on these proteins.  Future studies on these proteins could provide a greater 
understanding into cell signaling processes, disease progression, and even possible treatments for 






Table 6. Methionines that were more conserved than the surroundings and were at least 
70% conserved in all 3 graphs (Fig. 6-8) 
Actin, alpha cardiac muscle 1 
192 
229 



















BPI fold-containing family B member 2 
254 




































Table 6 (Cont.) 
Keratin, type I cytoskeletal 10 
306 
Keratin, type I cytoskeletal 14 
272 
Keratin, type I cytoskeletal 16 
274 
Keratin, type I cytoskeletal 9 
157 
326 
Keratin, type I cytoskeletal 14 
272 
Keratin, type I cytoskeletal 16 
274 
Keratin, type I cytoskeletal 9 
157 
326 
Keratin, type II cytoskeletal 1 
296 
Keratin, type II cytoskeletal 2 epidermal 
337 
Keratin, type II cytoskeletal 5 
284 








Table 6 (Cont.) 







Plasma protease C1 inhibitor 
324 































Table 7. Methionines that were more conserved than the surroundings and were at least 









Table 8. Methionines that were more conserved than the surroundings and were at least 
70% conserved in the graph comparing the N-terminus conservation and the graph 









Hemoglobin subunit beta 
56 
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Hemoglobin subunit delta 
56 










Table 9. Methionines that were more conserved than the surroundings and were at least 





Amyloid beta A4 
protein 
303 
Keratin, type I 
cytoskeletal 10 
291 







Table 10. Methionines that were more conserved than the surroundings and were at least 
70% conserved in the graph comparing the C-terminus conservation and the graph 














G-protein coupled receptor family C group 5 
member B 
381 
Keratin, type II cytoskeletal 1 
259 
469 
Keratin, type II cytoskeletal 5 
457 
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Maltase-glucoamylase, intestinal SV=2 
1623 


























Table 11. Conservation chart for proteins of interest with at least 80% conservation and at least 50% oxidation. Comparisons 
are shown between ConSurf chosen homologues at various distances on the phylogenetic tree (shown by close, mid, and far ranges), 











0.444 0.83 0.28 -0.646 
100% 
Color 4 2 4 8 
Confidence 
Interval 
0.085, 0.679 0.417, 1.145 -0.078, 0.438 -1.377, -0.328 
Confidence 
Interval Colors 
5, 3 4, 2 5, 4 9, 6 
229 Score 
(normalized) 
0.745 1.012 0.876 0.103 
96.97% 
Color 3 2 3 5 
Confidence 
Interval 
0.34, 0.907 0.604, 1.145 0.438, 1.058 -0.883, 0.583 
Confidence 
Interval Colors 











Table 11 (Cont.) 
Protein Methionine 
Position 
 Close Mid Far Clustal % 
Conservation 
eIF-2-alpha 





-0.27 -0.012 -0.828 0.222 
84.85% 
Color 6 5 8 4 
Confidence 
Interval 
-0.5, -0.176 -0.286, 0.172 





7, 6 6, 4 8, 8 6, 2 




-0.975 -1.001 -0.476 -0.833 
100% 
Color 8 8 6 9 
Confidence 
Interval 
-1.107, -0.914 -1.129, -0.937 





8, 8 8, 8 7, 6 9, 9 
Syntenin-1 57 Score 
(normalized) 
-1.038 -0.971 0.022 -0.914 
93.33% 
Color 9 9 5 9 
Confidence 
Interval 
-1.099, -1.013 -1.026, -0.93 -0.974, 0.74 -1.135, -0.835 
Confidence 
Interval Colors 







Table 11 (Cont.) 
Protein Methionine 
Position 
 Close Mid Far Clustal % 
Conservation 
Alpha-actinin-4 328 Score 
(normalized) 
0.125 0.515 -0.752 -0.649 
96.30% 
Color 4 3 7 8 
Confidence 
Interval 
-0.091, 0.253 0.076, 0.781 -1.195, -0.43 -0.935, -0.578 
Confidence 
Interval Colors 
5, 4 5, 2 8, 6 9, 8 
679 Score 
(normalized) 1.229 1.774 1.336 -0.649 
96.30% 
Color 1 1 2 8 
Confidence 
Interval 0.82, 1.614 0.781, 2.856 0.242, 2.06 -0.935, -0.578 
Confidence 
Interval Colors 2, 1 2, 1 4, 1 9, 8 
767 Score 
(normalized) 0.11 0.145 -0.11 0.77 
88.89% 
Color 5 4 5 1 
Confidence 
Interval -0.181, 0.253 -0.236, 0.361 -0.784, 0.385 -0.202, 1.117 
Confidence 







Table 11 (Cont.) 
Protein Methionine 
Position 





(normalized) -0.988 -0.991 -1.548 -0.649 
96.30% 
Color 9 9 8 8 
Confidence 
Interval -1.067, -0.952 -1.125, -0.94 
-2.119,          
-1.279 -0.935, -0.578 
Confidence 
Interval Colors 9, 9 9, 8 9, 8 9, 8 
Ezrin 200 Score 
(normalized) -1.213 -1.179 -0.865 -0.740 
100% 
Color 9 9 8 9 
Confidence 
Interval -1.238, -1.196 -1.252, -1.16 
-1.018,          
-0.774 -0.861, -0.702 
Confidence 




(normalized) -1.193 -1.432 -1.137 -1.232 
100% 
Color 9 9 8 9 
Confidence 
Interval -1.293, -1.159 -1.843, -1.252 
-1.255,           
-1.092 -1.391, -1.173 
Confidence 
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Protein Methionine 
Position 
 Close Mid Far Clustal % 
Conservation 
Keratin, type I 
cytoskeletal 16 
274 Score 
(normalized) -0.961 -0.871 -0.097 -0.879 
100% 
Color 8 8 5 9 
Confidence 
Interval -1.082, -0.88 -1.016, -0.797 -0.401, 0.033 -1.024, -0.830 
Confidence 




C group 5 
member B 
381 Score 
(normalized) -0.981 -1.108 -0.349 -1.158 
96.67% 
Color 8 8 6 9 
Confidence 
Interval -1.148, -0.862 -1.378, -0.976 -1.225, 0.244 -1.400, -1.046 
Confidence 
Interval Colors 9,8 9,8 8,4 9,9 
Plastin-3 169 Score 
(normalized) -0.701 -0.57 -0.531 -0.521 
96.67% 
Color 7 7 6 7 
Confidence 
Interval -0.856, -0.572 -0.781, -0.463 
-0.947,          
-0.283 -0.931, -0.301 
Confidence 


















(normalized) -1.181 -1.123 -1.141 -0.852 
96.55% 
Color 9 9 8 9 
Confidence 
Interval -1.247, -1.125 -1.211, -1.106 
-1.254,           
-1.106 -1.042, -0.752 
Confidence 




(normalized) -0.732 0.222 0.3 -0.545 
96.43% 
Color 8 4 4 9 
Confidence 
Interval -0.937, -0.593 -0.22, 0.574 
-0.712, 
1.1015 -0.689, -0.547 
Confidence 
Interval Colors 9,7 6,3 7,3 9,9 
Serpin B12 41 Score 
(normalized) -1.091 -0.966 -1.14 -1.008 
96.15% 
Color 8 9 8 9 
Confidence 
Interval -1.254, 0.975 -1.074, -0.93 
-1.353,          
-1.036 -1.225, -0.903 
Confidence 


















(normalized) -0.042 -0.54 -0.534 1.817 
93.55% 
Color 5 7 6 1 
Confidence 
Interval -0.383, 0.117 -0.726, -0.427 
-0.805,           
-0.356 -0.214, 3.139 
Confidence 
Interval Colors 6,5 7,6 7,6 7,1 
Glypican-3 316 Score 
(normalized) 0.497 0.927 -0.238 -0.676 
93.10% 
Color 3 2 6 8 
Confidence 
Interval 0.148, 0.64 0.19, 1.330 
-0.472,          
-0.102 -1.015, -0.504 
Confidence 





(normalized) 0.421 0.756 1.521 -0.839 
93.10% 
Color 4 3 1 9 
Confidence 
Interval 0.069, 0.553 0.373, 0.813 1.017, 1.906 -0.952, -0.803 
Confidence 











Close Mid Far Clustal 
% 
Conservation 
Keratin, type I 
cytoskeletal 13 
341 Score 
(normalized) -0.341 -0.176 -0.803 -0.386 
92.31% 
Color 6 6 7 7 
Confidence 
Interval -0.519, -0.253 -0.373, -0.052 
-0.996,          
-0.667 -0.691, -0.198 
Confidence 
Interval Colors 7,6 6,5 8,7 9,6 
Heat shock 
cognate 71 kDa 
protein 
61 Score 
(normalized) -0.277 1.407 -0.605 0.225 
90.91% 
Color 6 1 6 4 
Confidence 
Interval -0.451, -0.193 0.904, 1.367 
-0.862,           
-0.434 -0.538, 0.678 
Confidence 






(normalized) -1.136 ERROR -1.67 -1.435 
90% 
Color 9 ERROR 9 8 
Confidence 
Interval -1.322, -1.024 ERROR 
-2.025,          
-1.537 -1.965, -1.227 
Confidence 











Close Mid Far Clustal 
% 
Conservation 
Histone H3.1 94 Score 
(normalized) 2.621 2.537 0.523 2.121 
90% 
Color 1 1 4 1 
Confidence 
Interval 1.544, 2.797 1.442, 2.69 0.083, 0.758 0.704,2.559 
Confidence 
Interval Colors 1,1 1,1 5,3 1,1 
Keratin, type I 
cytoskeletal 10 
291 Score 
(normalized) -0.583 -0.17 -0.382 -0.673 
78.26% 
Color 7 6 6 8 
Confidence 
Interval -0.793, -0.409 -0.442, -0.013 
-0.629,           
-0.265 -1.009, -0.496 
Confidence 
Interval Colors 7,6 6,5 7,6 9,7 
306 Score 
(normalized) -1.154 -1.02 -1.124 -1.013 
100% 
Color 8 8 9 9 
Confidence 
Interval -1.267, -1.078 -1.138, -0.931 
-1.245,          
-1.087 -1.192, -0.933 
Confidence 











Close Mid Far Clustal 
% 
Conservation 
Keratin, type II 
cytoskeletal 6A 
242 Score 
(normalized) -0.286 -0.158 -0.507 -0.442 
88.46% 
Color 6 6 6 7 
Confidence 
Interval -0.473, -0.2 -0.378, -0.057 -0.708, -0.37 -0.726, -0.260 
Confidence 
Interval Colors 7,6 6,5 7,6 9,6 
Titin 16670 Score 
(normalized) ERROR ERROR ERROR ERROR 
88% 
Color ERROR ERROR ERROR ERROR 
Confidence 
Interval ERROR ERROR ERROR ERROR 
Confidence 
Interval Colors ERROR ERROR ERROR ERROR 
Profilin-1 86 Score 
(normalized) -1.027 -0.773 -0.901 -0.764 
86.67% 
Color 8 7 7 7 
Confidence 
Interval -1.211, -0.909 -1.11, -0.536 
-1.245,           
-0.697 -1.242, -0.461 
Confidence 

















(normalized) -0.123 2.215 ERROR 0.728 
85.71% 
Color 6 1 ERROR 2 
Confidence 
Interval -0.373, 0.001 0.984, 3.863 ERROR -0.175, 1.264 
Confidence 





(normalized) -1.047 -1.198 ERROR -1.006 
84.38% 
Color 9 9 ERROR 8 
Confidence 
Interval -1.11, -1.013 -1.325, -1.16 ERROR -1.219, -0.877 
Confidence 
Interval Colors 9,9 9,9 ERROR 9,8 
Keratin, type I 
cytoskeletal 12 
251 Score 
(normalized) 0.068 0.144 -0.178 0.116 
80.77% 
Color 5 5 5 5 
Confidence 
Interval -0.159, 0.251 -0.167, 0.253 
-0.426,          
-0.001 -0.450, 0.397 
Confidence 


















(normalized) -0.572 -0.517 -1.077 -0.697 
80.77% 
Color 7 7 8 7 
Confidence 
Interval -0.774, -0.422 -0.67, -0.389 
-1.231,           
-0.975 -1.040, -0.442 
Confidence 




(normalized) -1.161 -1.067 -1.188 -0.820 
90.63% 
Color 9 9 8 9 
Confidence 
Interval -1.232, -1.128 -1.1, -1.057 
-1.338,          
-1.112 -0.981, -0.716 
Confidence 
Interval Colors 9,9 9,9 9,8 9,8 
198 Score 
(normalized) -0.167 -0.063 -0.901 0.419 
59.375% 
Color 6 5 8 3 
Confidence 
Interval -0.388, 0.011 -0.268, 0.057 
-1.112,          
-0.753 -0.084, 0.855 
Confidence 

















(normalized) 0.374 0.279 0.296 -0.264 
84.38% 
Color 4 4 4 6 
Confidence 
Interval 0.011, 0.487 0.057, 0.378 -0.106, 0.429 -0.575, -0.084 
Confidence 
Interval Colors 5,3 5,4 5,4 8,5 
338 Score 
(normalized) -0.865 -0.587 -0.466 -0.696 
93.75% 
Color 8 7 6 8 
Confidence 
Interval -0.969, -0.778 -0.717, -0.558 -0.687, -0.3 -0.898, -0.575 
Confidence 












Table 12. Conservation chart for proteins of interest with at least 80% conservation and less than 50% oxidation showing 
comparisons between ConSurf chosen homologs at various distances on the phylogenetic tree (shown by close, mid, and far 
ranges), ConSurf calculations using a Clustal alignment of sequences from the set list of species, and the calculated % total 
conservation without using ConSurf 
Protein Methionine 
Position 
 Close Mid Far Clustal % 
Conservation 
Kallikrein-1 122 Score 
(normalized) 
ERROR -1.101 -1.127 -1.172 100% 
Color ERROR 9 8 9 
Confidence 
Interval 





ERROR 9,9 9,8 9,9 
197 Score 
(normalized) 
ERROR -1.201 -0.834 -1.172 100% 
Color ERROR 9 7 9 
Confidence 
Interval 
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Protein Methionine 
Position 
 Close Mid Far Clustal % 
Conservation 
Lysozyme C 35 Score 
(normalized) 
-0.190 -0.279 -0.230 ERROR 100% 
Color 6 6 6 ERROR 
Confidence 
Interval 
-0.443, -0.085 -0.543, -0.103 -0.813, 0.059 ERROR 
Confidence 
Interval Colors 
6,5 7,5 7,5 ERROR 





-1.208 -1.313 -1.096 -0.905 95.833% 
Color 9 9 8 8 
Confidence 
Interval 










0.465 0.004 -0.839 1.579 84.848% 
Color 4 5 7 1 
Confidence 
Interval 
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Protein Methionine 
Position 







-0.831 -0.660 -0.827 -1.136 100% 
Color 8 7 7 9 
Confidence 
Interval 











-0.840 -0.935 0.327 -0.751 91.667% 
Color 8 8 4 8 
Confidence 
Interval 
-0.960, -0.761 -1.305, -0.688 -0.300, 0.668 -1.041, -0.579 
Confidence 
Interval Colors 







-0.974 -1.048 -1.324 -0.713 90.909% 
Color 9 9 8 7 
Confidence 
Interval 












Table 12 (Cont.) 
Protein Methionine 
Position 
 Close Mid Far Clustal % 
Conservation 
Cadherin-13 267 Score 
(normalized) 
-0.989 -1.035 -0.852 -0.184 89.655% 
Color 8 8 7 6 
Confidence 
Interval 











-0.299 -0.423 0.035 0.379 69.565% 
Color 6 6 5 4 
Confidence 
Interval 
-0.542, -0.182 -0.587, -0.328 -0.306, 0.227 -0.220, 0.803 
Confidence 
Interval Colors 
7,6 7,6 6,4 6,2 
337 Score 
(normalized) 
-1.170 -1.184 -0.551 -1.110 100% 
Color 9 9 7 9 
Confidence 
Interval 
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Protein Methionine 
Position 
 Close Mid Far Clustal % 
Conservation 






-0.896 -0.814 -1.329 -0.641 91.304% 
Color 8 8 9 8 
Confidence 
Interval 











-0.341 0.290 2.572 -0.430 87.5% 
Color 6 4 1 7 
Confidence 
Interval 
-0.567, 0.202 -0.080, 0.485 1.255, 3.117 -0.730, -0.202 
Confidence 
Interval Colors 
7,6 5,3 2,1 8,6 
223 Score 
(normalized) 
-0.706 -0.615 0.244 -0.819 93.75% 
Color 7 7 4 8 
Confidence 
Interval 
-0.872, -0.637 -0.770, -0.500 -0.124, 0.451 -1.016, -0.679 
Confidence 
Interval Colors 
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Protein Methionine 
Position 







0.794 1.149 1.196 -0.089 75% 
Color 2 1 2 5 
Confidence 
Interval 
0.422, 1.013 0.485, 1.294 0.657, 1.255 -0.505, 0.118 
Confidence 
Interval Colors 
4,2 3,1 3,2 7,5 
Pro-cathepsin H 200 Score 
(normalized) 
-0.122 -0.076 0.010 -0.675 84.848% 
Color 5 5 5 8 
Confidence 
Interval 
-0.328, -0.022 -0.242, 0.004 -0.217, 0.149 -0.894, -0.538 
Confidence 
Interval Colors 






1.652 1.080 0.690 1.131 55.172% 
Color 1 1 3 1 
Confidence 
Interval 
1.215, 1.742 0.614, 1.216 0.226, 0.847 0.530, 1.336 
Confidence 
Interval Colors 
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Protein Methionine 
Position 








-1.336 -1.234 -1.456 -0.749 93.103% 
Color 9 9 9 8 
Confidence 
Interval 





9,9 9,9 9,9 9,7 
307 Score 
(normalized) 
-0.706 -0.808 -0.865 -0.844 93.103% 
Color 7 8 7 8 
Confidence 
Interval 










-0.942 -0.766 -0.764 -0.462 83.333% 
Color 8 7 7 7 
Confidence 
Interval 
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Protein Methionine 
Position 








-0.069 0.083 -0.271 0.261 83.871% 
Color 5 5 7 4 
Confidence 
Interval 





6,5 6,4 8,7 6,2 
277 Score 
(normalized) 
-0.054 0.127 0.305 -0.252 90.323% 
Color 5 5 4 6 
Confidence 
Interval 
-0.383, 0.073 -0.230, 0.273 -0.118, 0.586 -0.635, -0.076 
Confidence 
Interval Colors 
6,5 6,4 5,3 8,5 
Fibronectin 926 Score 
(normalized) 
-0.125 -0.602 ERROR 0.330 87.5% 
Color 6 7 ERROR 3 
Confidence 
Interval 
-0.415, 0.021 -1.366, -0.145 ERROR -0.311, 0.829 
Confidence 
Interval Colors 







Table 12 (Cont.) 
Protein Methionine 
Position 






0.610 -0.144 ERROR -0.730 95.833% 
Color 3 6 ERROR 9 
Confidence 
Interval 
0.136, 0.805 -0.949, 0.424 ERROR -0.946, -0.668 
Confidence 
Interval Colors 
4,2 8,4 ERROR 9,8 
1548 Score 
(normalized) 
-0.439 -0.704 ERROR -0.088 91.667% 
Color 7 7 ERROR 5 
Confidence 
Interval 
-0.715, -0.263 -1.366, -0.264 ERROR -0.572, 0.233 
Confidence 
Interval Colors 
8,6 9,6 ERROR 8,4 
1783 Score 
(normalized) 
-0.929 -1.250 ERROR -0.730 95.833% 
Color 9 9 ERROR 9 
Confidence 
Interval 
-1.077, -0.855 -1.818, -0.949 ERROR -0.946, -0.668 
Confidence 
Interval Colors 
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